Take Your Trading To The Next Level. Get Started Here!

Novo Nordisk CEO says experimental weight loss pill could become a best-in-class drug

March 8, 2024 Comments Off

Lars Fruergaard Jørgensen’s remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin.